Hepatitis B immune globulin (Emergent BioSolutions)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B immune globulin (Emergent BioSolutions)
Drug Alias NameHepaGam BImmunoGam
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2006/01/27
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAptevoCangene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCangene Europe Ltd
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksN/A